UK could allow reciprocal drug approvals with US FDA as soon as 2024

An intellectual property law firm says that recent guidance from the UK’s Medicines and Healthcare products Regulatory Agency hints at the possibility of the agency allowing approvals from other regulators, including possibly the US FDA, to play a role in UK regulatory processes.